Saturday, 20 November 2010

Aldactone




In some countries, this medicine may only be approved for veterinary use.


In the US, Aldactone (spironolactone systemic) is a member of the following drug classes: aldosterone receptor antagonists, potassium-sparing diuretics and is used to treat Acne, Alopecia, Edema, Heart Failure, High Blood Pressure, Hirsutism, Hypokalemia, Primary Hyperaldosteronism and Primary Hyperaldosteronism Diagnosis.

US matches:

  • Aldactone

UK matches:

  • Aldactone 25mg, 50mg and 100mg Tablets (SPC)

Ingredient matches for Aldactone



Potassium Canrenoate

Potassium Canrenoate is reported as an ingredient of Aldactone in the following countries:


  • Austria

  • Czech Republic

  • Germany

Spironolactone

Spironolactone is reported as an ingredient of Aldactone in the following countries:


  • Argentina

  • Australia

  • Austria

  • Bahrain

  • Belgium

  • Benin

  • Brazil

  • Burkina Faso

  • Cameroon

  • Canada

  • Central African Republic

  • Chad

  • Colombia

  • Congo

  • Costa Rica

  • Cote D'ivoire

  • Croatia (Hrvatska)

  • Cyprus

  • Ecuador

  • Egypt

  • El Salvador

  • Ethiopia

  • France

  • Gabon

  • Germany

  • Ghana

  • Greece

  • Guatemala

  • Guinea

  • Honduras

  • Hong Kong

  • Iceland

  • India

  • Indonesia

  • Ireland

  • Israel

  • Italy

  • Jordan

  • Kenya

  • Lebanon

  • Luxembourg

  • Madagascar

  • Mali

  • Malta

  • Mauritania

  • Mauritius

  • Mexico

  • Myanmar

  • Niger

  • Nigeria

  • Norway

  • Oman

  • Panama

  • Philippines

  • Portugal

  • Saudi Arabia

  • Senegal

  • Singapore

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Thailand

  • Togo

  • Tunisia

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

  • Zaire

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment